PR-negative breast cancer

Clinical trials for PR-negative breast cancer explained in plain language.

Never miss a new study

Get alerted when new PR-negative breast cancer trials appear

Sign up with your email to follow new studies for PR-negative breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

New drug combo aims to wipe out Triple-Negative breast cancer before surgery

Disease control Recruiting now

This phase 2 study is testing a drug called sacituzumab govitecan, alone or with pembrolizumab, given before surgery to people with localized triple-negative breast cancer. The goal is to see if these drugs can eliminate all cancer cells in the breast and lymph nodes before surge…

Matched conditions: PR-NEGATIVE BREAST CANCER

Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC

PR-negative breast cancer

Get alerted when new PR-negative breast cancer trials appear

New drug combo aims to wipe out Triple-Negative breast cancer before surgery